Bibliography
- YOUNG D, DRAGUNOW M: Status epilepticus may be caused by loss of adenosine anticonvulsant mechanism. Neuroscience (1994) 58:245–261.
- SIDERAKI V, WILSON DK, KURZ LC et al.: Site-directed mutagenesis of histidine 238 in mouse adenosine deaminase: substitution of histidine 238 does not impede hydroxylate formation. Biochemistry (1996) 35:15019–15028.
- WANG Z, QUIOCHO FA: Complexesof adenosine deaminase with two potent inhibitors: X-ray structures in four independent molecules at pH of maximum activity. Biochemistry (1998) 37:8314–8324.
- HOSMANE RS, HONG MY: How important is the N-3 sugar moiety in the tight-binding interaction of coformycin with adenosine-deaminase? Biochem. Biophys. Res. Commun. (1997) 236:88–93.
- CRISTALLI C, COSTANZI S, LAMBERTUCCI C et al: Adenosine deaminase: functional implication and different classes of inhibitors. Med. Res. Rev (2001) 21(2):105–128.
- ••Most recent comprehensive review on ADA.
- CRISTALLI G, ELEUTERI A, VITTORI S et al.: Adenosine deaminase inhibitors: synthesis and structure—activity relationships of imidazole analogues of erythro 9 (2 hydroxy-3-nonyl) adenine. J. Med. Chem. (1991) 34:1187–1192.
- •First report of imidazole analogues as ADA inhibitors.
- CRISTALLI G, ELEUTERI A, VITTORI S et al.: Adenosine-deaminase inhibitors-structure—activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogs. Drug. Dev. Res. (1993) 28:253–258.
- CRISTALLI G, ELEUTERI A, VOLPINI R et al.: Adenosine deaminase inhibitors: synthesis and structure—activity relationships of 2-hydroxy-3-nonyl derivatives of azoles..1. Med. Chem. (1994) 37:201–205.
- VOLPINI R, CAMAIONI E, LUPIDI Get al.: Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nony1)-1,2,4-triazole-3- carboxamide. Farmaco (1997) 52:429–433.